|
��չ����
|
|
| ������Ϣ | |
 |
Supporting info |
|
PDFȫ�� |
|
[HTMLȫ��] |
|
����� |
| �����뷴�� | |
|
�������ù����� |
|
���� |
|
Email Alert |
|
���·��� |
|
���������Ϣ |
| ���Ĺؼ���������� | |
|
�������� |
|
��� |
| ��������������� | |
|
�������� |
|
��Ȫ���� |
|
֣ï����У |
|
�˾���У |
| PubMed | |
|
Article by |
|
Article by |
|
Article by |
|
Article by |
�������������
��������, ��Ȫ����, ֣ï����У, �˾���У
�ڶ���ҽ��ѧ����ҽԺƤ����
�������ӿɷ�Ϊ4���Ǽ���,��ͬ�������������õİ�ϸ��������ͬ.����������������G����ż�����峬����,���������ӹ�ͬ��ɸ���������.��м������Ƥ���е���ϸ����������-1������-8����-������ذ�����-�������յ��ĵ������ӡ���-�������յ����ס����ɵ��ڵġ�����Tϸ����ﲢ���ܷ��ڵ����ӵı����������˲�ͬ,����������������ϸ����Tϸ����Ƥ��ֲ�,����-8����-������ذ����������ڽ����γ�ϸ��ʹ��߶���ֳ�����ֳ���м�����ٴ�����������.�����м������Ƥ�����������Ӽ�������ĸı�,���ܼ��ֿ���м��ҩ����µ����û���.
[2] Mohamadzadeh M,Poltorak AN,Bergstressor PR,et al.lDendritic cells produce macrophage inflammatory protein-1 gamma,a new member of the CC chemokine family.J Immunol,1996,156(9):3102-3106.
[3] Gillitzer R,Ritter U,Spandau U,et al.Differential expression of GROalpha and IL-8 mRNA in psoriasis:a model for neutrphil migration and accumulation in vivo.J Invest Dermatol,1996,107(5):635-643.
[4] Nakamura K,Williams IR,Kupper TS,et al.keratinocyte-derived monocyte chemoattractant protein 1(MCP-1):analysis in a transgenic model demonstrates MCP-1 can recruit dendritic and Langerhans cells to skin.J Invest Dermatol,1995,105(5):635-643.
[5] Goebeler M,Toksoy A,Spandau U,et al.The C-X-C chemokine Mig is highly expressed in the papillae of psoriatic lesions.J Pathol,1998,184(1):89-95.
[6] Boorsma DM,Flier J,Sampat S,et al.Chermokine IP-10 expression in cultured human keratinocytes.Arch Dermatol Res,1998,290(6):335-341.
[7] Luster AD,Cardiff RD,MacLean JA,et al.Delayed wound healing and disorganized neovascularization in transgenic mice expressing tbe IP-10chemokine.Proc Assoc Am Physicians,1998,110(3):183-196.
[8] Raychaudhuri SP,Jiang WY,Farber EM,et al.Upregulation of RA NTES in psoriatic keratinocytes:a possible pathogenic mechanism for psoriasis.Acta Derm Venereol,1999,79(1):9-11.
[9] Kulke R,Bomscheuer E,Schluter C,et al.The CXC receptor 2 is overexpressed in psoriatic epidermis.J Invest Dermatol,1998,110(1):90-94.
[10] Kondo S,Yoneta A,Yazawa H,et al.Downregulation of CXCR-2 but not CXCR-1 expression by human keratinocytes by UV B.J Cell Physiol,2000,182(3):366-370.
[11] Raychaudhuri SK,Raychaudhuri SP,Farber EM.Anti-chemotactic activities of peptide-T:a possible mechanism of actions for its therapeutic effects on psoriasis.Int J Immunopharmacol,1998,20(11):661-667.
[12] Fukuoka M,Ogino Y,Sato H,et al.RANTES expression in lsoriatic skin,and regulation of RANTFS and IL-8 production in cultured epidermal keratinocytes by active vitamin D3(tacalcitol).Br J Dematol,1998,138(1):63-70.